13. Fetal and Neonatal Electrocardiography and Arrhythmias
The fetal and neonatal periods represent vulnerable physiological transitions where electrical disturbances directly threaten systemic perfusion and neurodevelopment.
1. Clinical Presentation & Fetal Surveillance
- Fetal Arrhythmias: Detected during routine obstetric Doppler auscultation as persistent fetal tachycardia ($FHR > 160-180\text{ bpm}$), sustained fetal bradycardia ($FHR < 110\text{ bpm}$), or irregular cardiac rhythm.
- Non-Immune Hydrops Fetalis: Scalp edema, pleural effusion, pericardial effusion, and ascites resulting from low-output heart failure secondary to sustained tachyarrhythmias (SVT, A-flutter) or complete heart block.
- Neonatal Myocardial Injury: Infants with Hypoxic-Ischemic Encephalopathy (HIE) presenting with hypotension, poor capillary refill, and elevated cardiac troponins.
2. Electrocardiographic Manifestations in the Neonate
| Condition | Primary Electrocardiographic Hallmarks | Clinical Significance |
|---|---|---|
| Transient Myocardial Ischemia of the Newborn (TMIN) | Deep T-wave inversions in left precordial leads ($V_5-V_6$) and inferior leads; ST segment depression $>2\text{ mm}$; transient pathological $Q$ waves. | Seen in perinatal asphyxia; reversible with supportive inotropic support. |
| Neonatal Atrial Flutter | Continuous sawtooth flutter waves ($F$ waves) at rates of $350-450\text{ bpm}$ with $2:1$ or $3:1$ AV conduction. | Usually occurs in structurally normal hearts; single electrical cardioversion is curative with zero recurrence. |
| Persistent Pulmonary Hypertension of Newborn (PPHN) | Extreme right axis deviation ($>+180^\circ$), tall monophasic $R$ in $V_1$, $qR$ in $V_1$, upright $T$ in $V_1$, deep $S$ in $V_6$. | Reflects suprasystemic right ventricular pressures. |
| Hemodynamically Significant PDA (hsPDA) in Preterm | Deep $Q$ waves ($>4\text{ mm}$) and tall $R$ waves in $V_5-V_6$ with ST depression; prominent P-mitrale. | Indicates massive left-to-right ductal volume overload of the left atrium and ventricle. |
3. Multimodality Diagnostic Investigations
- Fetal Echocardiography: High-resolution Doppler interrogation of the fetal mechanical PR interval, ventricular ejection fraction, and hydrops staging.
- Serum Cardiac Biomarkers: Serial high-sensitivity Troponin-T and NT-proBNP in asphyxiated neonates.
4. Evidence-Based Clinical Management Protocols
- Transplacental Fetal Antiarrhythmic Therapy:
- Maternal oral Digoxin, Flecainide ($200-300\text{ mg/day}$), or Sotalol for fetal SVT and Atrial Flutter.
- Neonatal Atrial Flutter Termination:
- Synchronized DC Cardioversion ($0.5-1.0\text{ J/kg}$) or rapid transesophageal atrial overdrive pacing.
- Targeted Medical Closure of Preterm hsPDA:
- IV Paracetamol / Acetaminophen ($15\text{ mg/kg}$ q6h for 3-5 days) or IV Ibuprofen ($10\text{ mg/kg}$ then $5\text{ mg/kg/day}$).